Clinical trial

Drug-Drug Interaction Study in Trans Women Living With HIV

NCT05663892

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Biktarvy 50/200/25 Tab Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Estradiol Tablets Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Drug-Drug Interaction Study in Trans Women Living With HIV

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2022-11-23

PhasePHASE4

Conditions

Hivunresolved

Transgenderismunresolved

Interventions

Biktarvy 50/200/25 TabDRUG

Estradiol TabletsDRUG

Sponsors & collaborators

Maple Leaf Researchlead sponsor

Mapped research locations

TorontoOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05663892 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.